These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38063198)

  • 1. Single-cell transcriptomics reveals variations in monocytes and Tregs between gout flare and remission.
    Yu H; Xue W; Yu H; Song Y; Liu X; Qin L; Wang S; Bao H; Gu H; Chen G; Zhao D; Tu Y; Cheng J; Wang L; Ai Z; Hu D; Wang L; Peng A
    JCI Insight; 2023 Dec; 8(23):. PubMed ID: 38063198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MSU crystal deposition contributes to inflammation and immune responses in gout remission.
    Gu H; Yu H; Qin L; Yu H; Song Y; Chen G; Zhao D; Wang S; Xue W; Wang L; Ai Z; Xu B; Peng A
    Cell Rep; 2023 Oct; 42(10):113139. PubMed ID: 37756161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell transcriptomics reveals variations in monocytes and Tregs between gout flare and remission.
    Yu H; Xue W; Yu H; Song Y; Liu X; Qin L; Wang S; Bao H; Gu H; Chen G; Zhao D; Tu Y; Cheng J; Wang L; Ai Z; Hu D; Wang L; Peng A
    JCI Insight; 2024 Feb; 9(3):. PubMed ID: 38329132
    [No Abstract]   [Full Text] [Related]  

  • 4. Flare Rate Thresholds for Patient Assessment of Disease Activity States in Gout.
    Taylor W; Dalbeth N; Saag KG; Singh JA; Rahn EJ; Mudano AS; Chen YH; Lin CT; Tan P; Louthreno W; Vazquez-Mellado J; Hernández-Llinas H; Neogi T; Vargas-Santos AB; Castelar-Pinheiro G; Chaves-Amorim RB; Uhlig T; Hammer HB; Eliseev M; Perez-Ruiz F; Cavagna L; McCarthy GM; Stamp LK; Gerritsen M; Fana V; Sivera F; Gaffo AL
    J Rheumatol; 2021 Feb; 48(2):293-298. PubMed ID: 32358154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulated expression of FFAR2 and SOC3 genes is associated with gout.
    Orji OC; López-Domínguez MB; Sandoval-Plata G; Guetta-Baranes T; Valdes AM; Doherty M; Morgan K; Abhishek A
    Rheumatology (Oxford); 2023 Feb; 62(2):977-983. PubMed ID: 35731142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epigenome: key to understanding and predicting gout flares.
    Wolyncewicz B; Major TJ; Delahunt B; Thunders M
    Pathology; 2021 Dec; 53(7):824-829. PubMed ID: 34657735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monosodium urate burden assessed with dual-energy computed tomography predicts the risk of flares in gout: a 12-month observational study : MSU burden and risk of gout flare.
    Pascart T; Grandjean A; Capon B; Legrand J; Namane N; Ducoulombier V; Motte M; Vandecandelaere M; Luraschi H; Godart C; Houvenagel E; Norberciak L; Budzik JF
    Arthritis Res Ther; 2018 Sep; 20(1):210. PubMed ID: 30223875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monosodium urate crystals alter the circadian clock in macrophages leading to loss of NLRP3 inflammasome repression: Implications for timing of the gout flare.
    Popov D; Jain L; Alhilali M; Dalbeth N; Poulsen RC
    FASEB J; 2023 Jun; 37(6):e22940. PubMed ID: 37243314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum CA72-4 predicts gout flares during urate lowering therapy initiation: a prospective cohort study.
    Hu S; Sun M; Li M; Xue X; Terkeltaub R; Wang C; Wang M; Lu J; Ran Z; Li H; Ji A; Sun W; Li X; He Y; Liu Z; Zhang H; Wang X; Ji X; Dalbeth N; Li C
    Rheumatology (Oxford); 2023 Jul; 62(7):2435-2443. PubMed ID: 36409036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Vaccination and Gout Flare Risk in Patients With Infrequent or Frequent Flares: A Prospective Cohort Study.
    He Y; Xue X; Dalbeth N; Terkeltaub R; Chen Y; Yan F; Pang L; Li X; Yuan X; Cheng X; Li C; Sun M
    Arthritis Care Res (Hoboken); 2024 Jan; 76(1):131-139. PubMed ID: 37553607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma adsorption in refractory chronic gouty arthritis flare: A case report.
    Lei Y; Cui TJ; Wang XH; Zhang XM; Tang C; Zheng ZH
    Front Immunol; 2022; 13():1045982. PubMed ID: 36505444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell RNA sequencing of immune cells in patients with acute gout.
    Chang JG; Tu SJ; Huang CM; Chen YC; Chiang HS; Lee YT; Yen JC; Lin CL; Chung CC; Liu TC; Chang YS
    Sci Rep; 2022 Dec; 12(1):22130. PubMed ID: 36550178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical activity measured using wearable activity tracking devices associated with gout flares.
    Elmagboul N; Coburn BW; Foster J; Mudano A; Melnick J; Bergman D; Yang S; Chen L; Filby C; Mikuls TR; Curtis JR; Saag K
    Arthritis Res Ther; 2020 Aug; 22(1):181. PubMed ID: 32746893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-hoc analysis of pegloticase pivotal trials in chronic refractory gout: relationship between fluctuations in plasma urate levels and acute flares.
    Mandell BF; Fields TR; Edwards NL; Yeo AE; Lipsky PE
    Clin Exp Rheumatol; 2021; 39(5):1085-1092. PubMed ID: 33427618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating gout flares: beyond a definition.
    Sutherland C; Gaffo AL
    Curr Opin Rheumatol; 2024 Jul; 36(4):309-313. PubMed ID: 38695425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum CA72-4 is specifically elevated in gout patients and predicts flares.
    Bai X; Sun M; He Y; Liu R; Cui L; Wang C; Wan F; Wang M; Li X; Li H; Wu X; Li C
    Rheumatology (Oxford); 2020 Oct; 59(10):2872-2880. PubMed ID: 32087013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How flare prevention outcomes are reported in gout studies: A systematic review and content analysis of randomized controlled trials.
    Stewart S; Tallon A; Taylor WJ; Gaffo A; Dalbeth N
    Semin Arthritis Rheum; 2020 Apr; 50(2):303-313. PubMed ID: 31796212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation Status of NLRP3 Inflammasome in Peripheral Blood Mononuclear Cells From Patients With Gout Flare.
    Amezcua-Castillo LM; Juárez-Vicuña Y; Márquez-Velasco R; Amezcua-Guerra LM
    J Clin Rheumatol; 2020 Oct; 26(7S Suppl 2):S208-S212. PubMed ID: 32332275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gout Flares and Mortality After Sodium-Glucose Cotransporter-2 Inhibitor Treatment for Gout and Type 2 Diabetes.
    Wei J; Choi HK; Dalbeth N; Li X; Li C; Zeng C; Lei G; Zhang Y
    JAMA Netw Open; 2023 Aug; 6(8):e2330885. PubMed ID: 37624597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which Attributes Are Most and Least Important to Patients When Considering Gout Flare Burden Over Time? A Best-worst Scaling Choice Study.
    Holyer J; Taylor WJ; Gaffo A; Hosie G; Horne A; Mihov B; Su I; Gamble GD; Dalbeth N; Stewart S
    J Rheumatol; 2022 Feb; 49(2):213-218. PubMed ID: 34725178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.